Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Oscotec Inc.
Oscotec Inc.
National Cancer Institute (NCI)
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Canadian Cancer Trials Group
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
National University Hospital, Singapore
University of Arizona
AmpliMed Corporation
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Emory University